KRT8P48: A Potential Drug Target and Biomarker (G100887067)

Target Name: KRT8P48

NCBI ID: G100887067

KRT8P48

Other Name(s): keratin 8 pseudogene 48 | Keratin 8 pseudogene 48

KRT8P48: A Potential Drug Target and Biomarker

Kruskalikoffa truncata subsp. KRT8P48 (KRT8P) is a protein that is expressed in various tissues of the human body, including the brain, pancreas, and heart. It is a member of the Kallikrein family of serpins, which are a group of transmembrane proteins that regulate various physiological processes in the body, including blood clotting and inflammation.

The KRT8P48 protein has been identified as a potential drug target due to its unique structure and the various functions it is involved in. One of the most significant functions of KRT8P48 is its role in blood clotting, which is critical for maintaining the integrity of blood vessels. In addition, KRT8P48 is also involved in the regulation of inflammation, which is important for maintaining the immune system's response to harmful substances in the body.

The potential drug target for KRT8P48 is related to its role in blood clotting and inflammation. Drugs that are currently being developed to treat various cardiovascular and inflammatory conditions, such as heart disease, cancer, and autoimmune disorders, are often designed to target molecules that are involved in these processes. By targeting KRT8P48, drugs could potentially provide new therapeutic options for treating these conditions.

Another potential benefit of targeting KRT8P48 is its potential to serve as a biomarker. The Kallikrein family of serpins is known for their ability to generate various biomarkers, including the serine protease Kallikrein-related peptidases (K-PPTs) and the kallikrein-related autoantibodies (KRAbs). These biomarkers are often used to diagnose and monitor various diseases, including cancer, autoimmune disorders, and cardiovascular disease. By targeting KRT8P48, researchers could potentially develop new diagnostic tests or biomarkers for these conditions.

In addition to its potential as a drug target and biomarker, KRT8P48 is also of interest to researchers due to its unique structure and the various functions it is involved in. The Kallikrein family of serpins consists of a variety of different proteins, each with a unique structure that allows them to perform distinct functions. KRT8P48 is one of the most well-studied of these proteins, and its unique structure has allowed researchers to gain new insights into its functions.

One of the most significant functions of KRT8P48 is its role in blood clotting. KRT8P48 is a potent inhibitor of the aggregation of platelet cells, which is a key step in the formation of blood clots. This means that KRT8P48 could potentially be used to treat blood clots, which are a leading cause of cardiovascular disease.

In addition to its role in blood clotting, KRT8P48 is also involved in the regulation of inflammation. It does this by participating in the regulation of the chemokine network, which is a complex system of signaling molecules that play a critical role in the immune system's response to harmful substances in the body.

Targeting KRT8P48 could potentially provide new therapeutic options for treating various cardiovascular and inflammatory conditions. By inhibiting the aggregation of platelet cells and regulating the chemokine network, KRT8P48 could potentially be used to treat blood clots and other cardiovascular diseases. In addition, KRT8P48 could also be used as a biomarker to diagnose and monitor various diseases.

Overall, KRT8P48 is a protein that has the potential to be a drug target and biomarker. Its unique structure and various functions make it an attractive target for researchers to study, and its potential to treat various cardiovascular and inflammatory conditions makes it an important molecule to

Protein Name: Keratin 8 Pseudogene 48

The "KRT8P48 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT8P48 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets